title: ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products.
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry; D004304:Dosage Forms; D004339:Drug Compounding; D004348:Drug Labeling / Q000592:standards*; D005283:Fentanyl / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry; D006801:Humans; D061214:Patient Safety; D055553:Prescription Drugs / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry; D012307:Risk Factors; D012955:Societies, Medical / Q000592:standards*; D014116:Toxicology / Q000592:standards*
chemical_list: D000701:Analgesics, Opioid; D004304:Dosage Forms; D055553:Prescription Drugs; D005283:Fentanyl
keywords: Fentanyl; Opioid; Position statement; Toxicology; Transmucosal